Stránka klinických studií Nct
Clinical Trial Results:
A randomised, double blind, placebo-controlled, double dummy, 4-way cross-over, dose ascending study to assess the safety, tolerability, pharmacodynamics and pharmacokinetics of single inhaled doses of GSK573719 (250, 500 and 1000µg) and tiotropium bromide (18µg) via DPI in COPD patients.
| Summary | |
EudraCT number | 2007-000187-25 |
Trial protocol | DE |
Global completion date | 06 Nov 2007 |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
| Results information | |
Results version number | v1(current) |
This version publication date | 06 Jul 2016 |
First version publication date | 06 Jul 2016 |
Other versions | |
Summary report(s) | 108123-FDAAA-Result-Summary |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.